- Exchange: OTC US
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for HST Global Inc (HSTC)
| Open: | - | Day's Range: | - | Volume: | 8,000 |
|---|---|---|---|---|---|
| Previous Close: | 0.0200 | 52wk Range: | 0.0010 - 0.0890 | 1-Yr Rtn: | - |
Key Statistics for HSTC
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(-) | - |
| Relative P/E vs. SPX | - |
| Earnings Per Share (ttm) | -0.0100 |
| Est. EPS | - |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 0.73 |
| Shares Outstanding (M) | 36.72 |
| 30 Day Average Volume | 983 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | -% |
| Cash Dividend | - |
| Last Dividend | |
| 5 Year Dividend Growth | - |
| Next Earnings Announcement | 06/03/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for HSTC
No data available
Company Profile & Key Executives for HSTC
HST Global, Inc. acquires and develops medications for the treatment of cancer.
| Ronald R Howell "Ron"Chairman/CEO/Interim CFO |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
HSTC News
-
Industry News
No stories found
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page